Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CROWE, Paul D")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

Novel benzothiophene H1-antihistamines for the treatment of insomniaMOREE, Wilna J; JOVIC, Florence; HERNANDEZ, Lisa M et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 7, pp 2316-2320, issn 0960-894X, 5 p.Article

Characterization of Novel Selective H1-Antihistamines for Clinical Evaluation in the Treatment of InsomniaMOREE, Wilna J; LI, Bin-Feng; BRADBURY, Margaret J et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 17, pp 5307-5310, issn 0022-2623, 4 p.Article

Brain-penetrating 2-aminobenzimidazole H1-antihistamines for the treatment of insomniaCOON, Timothy; MOREE, Wilna J; WEN, Jenny et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4380-4384, issn 0960-894X, 5 p.Article

Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZHIQIANG GUO; TELLEW, John E; MCCARTHY, James R et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 16, pp 5104-5107, issn 0022-2623, 4 p.Article

Influence of pKa on the biotransformation of indene H1-antihistamines by CYP2D6HUANG, Charles; MOREE, Wilna J; MADAN, Ajay et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 3, pp 947-951, issn 0960-894X, 5 p.Article

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsGROSS, Raymond S; ZHIQIANG GUO; GRIGORIADIS, Dimitri E et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 18, pp 5780-5793, issn 0022-2623, 14 p.Article

NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patientsCROWE, Paul D; YUFEN QIN; CONLON, Paul J et al.Annals of neurology. 2000, Vol 48, Num 5, pp 758-765, issn 0364-5134Article

Lead optimization of 2-(piperidin-3-yl)-1H-benzimidazoles: Identification of 2-morpholin- and 2-thiomorpholin-2-yl-1H-benzimidazoles as selective and CNS penetrating H1-antihistamines for insomniaBABU RAVULA, Satheesh; JINGHUA YU; HOARE, Samuel R. J et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 421-426, issn 0960-894X, 6 p.Article

Selectivity profiling of novel indene H1-antihistamines for the treatment of insomniaLI, Bin-Feng; MOREE, Wilna J; HOARE, Samuel R. J et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 8, pp 2629-2633, issn 0960-894X, 5 p.Article

The discovery and structure-activity relationships of 2-(piperidin-3-yl)-1H-benzimidazoles as selective, CNS penetrating H1-antihistamines for insomniaLAVRADOR-ERB, Karine; BABU RAVULA, Satheesh; CROWE, Paul D et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 9, pp 2916-2919, issn 0960-894X, 4 p.Article

Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor : Implications for structure-activity relationships and insurmountable antagonismSULLIVAN, Susan K; HOARE, Sam R. J; FLECK, Beth A et al.Biochemical pharmacology. 2006, Vol 72, Num 7, pp 838-849, issn 0006-2952, 12 p.Article

Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonistsLOWE, Richard F; NELSON, Jodene; SZABO, Thomas et al.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 5, pp 1540-1549, issn 0022-2623, 10 p.Article

Differential profile of CRF receptor distribution in the rat stomach and duodenum assessed by newly developed CRF receptor antibodiesCHATZAKI, Ekaterini; MURPHY, Brian J; LIXIN WANG et al.Journal of neurochemistry. 2004, Vol 88, Num 1, pp 1-11, issn 0022-3042, 11 p.Article

Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomniaMOREE, Wilna J; LI, Bin-Feng; HERNANDEZ, Lisa M et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 19, pp 5874-5878, issn 0960-894X, 5 p.Article

CRF receptor type 1 and 2 expression and anatomical distribution in the rat colonCHATZAKI, Ekaterini; CROWE, Paul D; LIXIN WANG et al.Journal of neurochemistry. 2004, Vol 90, Num 2, pp 309-316, issn 0022-3042, 8 p.Article

Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligandsHOARE, Sam R. J; SULLIVAN, Susan K; PAHUJA, Anil et al.Peptides (New York, NY. 1980). 2003, Vol 24, Num 12, pp 1881-1897, issn 0196-9781, 17 p.Article

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptideALLEVA, David G; GAUR, Amitabh; LING, Nicholas et al.Diabetes (New York, NY). 2002, Vol 51, Num 7, pp 2126-2134, issn 0012-1797Article

  • Page / 1